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Abstract 
Deoxynivalenol (DON) and ochratoxin A (OTA) are mycotoxins produced by fungal 
species which can contaminate, alone or simultaneously, cereal-based products such as bread. 
Due to the increasing interest in the beneficial effects of dietary bran, bran bread has attained 
high consumption. Usually, the higher mycotoxin concentrations in cereals are found in the 
external layers of the grain (bran), leading to higher concentration of DON and OTA in breads 
with added bran. Moreover, the use of sourdough in breadmaking is increasing, but no studies 
about its effect in the mycotoxins content exist. The objective of this study was to determine the 
variation of concentration of these mycotoxins during the breadmaking process including the 
following factors: two initial mycotoxin concentrations in the initial mix of ingredients, four different 
bran contents, and use of sourdough. OTA was confirmed to be quite stable during the 
breadmaking process, regardless of the assayed factors. DON concentration during breadmaking 
was not significantly affected by bran content of bread. However, it was significantly affected by 
kneading and fermentation steps in different way depending on sourdough use and flour 
contamination level: if DON reduction occurs during fermentation, this leads to a safer situation, 
but the possible increase in DON should be considered with care, as it can compensate the 
expected dilution effect by recipe. Finally, the results on deoxynivalenol-3-glucoside (DON-3-
glucoside), although preliminar, suggest an increase of this toxin during fermentation, but mainly 
during baking.  
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1. Introduction 
Wheat bread provides more nutrients to the world population than any other single food 
source (Peña, 2002). Bread is particularly important as a source of carbohydrates, proteins and 
vitamins B and E (Pomeranz, 1987). Consumption of bread prepared with whole grain flours is 
currently increasing in developed countries, due to the increasing interest in the beneficial effects 
of dietary fiber (Faridi and Faubion, 1995). Dietary fiber is defined as carbohydrate polymers with 
three or more monomeric units, which are neither digested nor absorbed in the human small 
intestine and which have a beneficial physiological effect demonstrated by generally accepted 
scientific evidence (European Comission, 2011). The benefits of dietary fiber intake are 
numerous, ranging from improved large bowel function to slowed digestion and absorption of 
carbohydrate and fat and reduced risk for certain diseases. Based on the effects on bowel 
function, the EFSA Panel considered bran intake of 25 g·d−1 to be adequate for normal laxation 
in adults (EFSA, 2010). 
Cereals and cereal based products like bread may contain mycotoxins, particularly 
deoxynivalenol (DON) and ochratoxin A (OTA). Wheat and wheat containing products (like bread 
and pasta) represent the major source of intake for DON (Cano-Sancho et al., 2011a; SCOOP, 
2003). 55% of samples (raw cereals and derived products) were reported to be OTA positive 
(SCOOP, 2002) and cereals are considered one of the major sources of intake for OTA (Coronel 
et al., 2012).  
DON, also known as vomitoxin, is one of the most regular contaminants in cereals (Alexa 
et al., 2013; Cano-Sancho et al., 2011b; EFSA, 2006a;  Jelinek et al., 1989; Li et al., 2014). 
Although DON is not classifiable as to its carcinogenicity to humans by the International Agency 
for Research on Cancer (IARC, 1993), it has been linked with human gastroenteritis (Pestka, 
2010a,b). At the molecular level, DON disrupts normal cell function by inhibiting protein synthesis, 
affecting cell signaling, differentiation, and proliferation. An acute and high dose of DON can 
induce vomiting, whereas chronic dietary exposure to DON causes reduced food intake, 
decreased nutritional efficiency, reduced weight gain, and immune dysregulation. OTA is a 
nephrotoxic mycotoxin which possesses carcinogenic, teratogenic, immunotoxic and possibly 
neurotoxic properties (EFSA, 2006b). This mycotoxin has been classified as a possible human 
carcinogen in the group 2B by the IARC (IARC, 2002). OTA has been reported in cereals, coffee, 
grape juice, wine, beer and meat based foodstuffs (Coronel et al., 2012).  
The European Commission has set a maximum permitted level for OTA in processed 
cereal products for direct human consumption of 3 µg·kg-1, and a maximum concentration of 500 
µg/kg for DON in bread (European Commission, 2006).  
Deoxynivalenol-3-glucoside (DON-3-glucoside) is a plant metabolite from DON, and then 
considered a masked mycotoxin. Berthiller et al. (2005) showed its high presence in wheat. Some 
studies pointed out a possible conversion of DON-3-glucoside to DON during baking (De Angelis 
et al., 2013). Moreover, Berthiller et al. (2011) showed that DON-3-glucoside can be hydrolised 
by several lactic acid bacteria. Thus the Joint European Commission FAO/WHO Expert 
Committee (JEFCA) considered DON-3-glucoside as an additional contributing factor of the total 
dietary exposure to DON (Codex, 2011; JEFCA, 2010).  
Nishio et al. (2010) studied the level of Fusarium graminearum infection in wheat and 
observed that the level of DON production was directly related to the incidence of fungal growth, 
and that fungal infection was greatest at or near the kernel surface. Generally, cereal bran is the 
part of the grain with the highest concentration of mycotoxins (Thammawong et al., 2010). L’Vova 
et al. (1998) reported that up to 60% of the initial DON content in grain passed into bran and that 
mycotoxin content in the bran exceeded that in the grain. Scudamore (2005) reported that by-
products such as 'cleanings' or bran may contain high concentrations of OTA. Vidal et al. (2012) 
assessed the content of several mycotoxins in wheat and oat based bran supplements sold in the 
Spanish market; DON was present in 42% of the samples, with levels above the EU legislation in 
19% of samples, whereas OTA was present in 25% of the samples.  
Thermal treatment of contaminated cereals, flour and bran may decrease the levels of 
mycotoxins. However, some studies with OTA contaminated flour reported that this mycotoxin is 
stable at high temperatures, and that its concentration does not decrease during baking 
(Scudamore, 2005; Vidal et al., 2014). Also, the studies of Bullerman and Bianchini (2007) and 
Kabak (2009) reported that DON is stable in processing steps involving high temperatures. By 
contrast, Scott et al. (1984) reported a reduction of DON up to 74% in white flour bread, although 
other studies reported lower reduction of DON during baking (Lancova et al., 2008; Pacin et al., 
2012; Vidal et al., 2014). DON stability during the baking process can be influenced by 
temperature, time and loaf size (Vidal et al., 2014). Finally, DON degradation may take place 
mostly in the bread crust, which reaches the highest temperature, whereas the content of DON 
in the breadcrumbs scarcely decreases (Kostelanka et al., 2011). Thus, the inactivation of DON 
and OTA during baking and the influence of bran content are not clear yet. It is obvious that the 
initial content of bran influences on the final content of mycotoxins in bread. Moreover, the effects 
of bran content of bread in toxin thermal stability may lead to different dynamics of the mycotoxin 
during baking.  
The interest in the use of sourdough in the manufacture of bakery products is increasing 
as a traditional added value; sourdough is a very complex biological ecosystem where yeasts and 
lactic acid bacteria contribute to the dough fermentation (Gobbetti, 1998).  
The objective of the assay presented herein was to assess the effect of dough 
fermentation and baking on DON and OTA content in bran bread combined with sourdough 
addition. For an additional experiment, OTA in the initial mixture came either from contaminated 
bran or contaminated flour, in order to study whether the source of the mycotoxin influences on 
its dynamics during dough fermentation and baking. Finally, DON-3-glucoside natural 
contamination was followed through the breadmaking process. 
 
2. Materials and methods 
2.1. DON and OTA contaminated flour and bran 
In order to obtain DON or OTA contaminated flour, two strains of either Fusarium 
graminearum (TA 3.234) or Aspergillus ochraceus (TA 3.201) were used. Both of them are kept 
in the Food Technology Dept. collection, University of Lleida, Spain. They were previously proved 
to be DON and OTA producers when cultured on wheat flour. The initial flour did not contain OTA, 
and DON and DON-3-glucoside levels (n=3) were 250±76 and 45.1±15.3 µg·kg-1, respectively. 
The strains were inoculated and incubated in MEA (malt extract agar) at 25 ºC until strong 
sporulation. A spore suspension of each strain was made in water and Tween 80 (0.005% v/v). 
Five milliliters of either F. graminearum or A. ochraceus spore suspension were inoculated in 
glass flasks containing 250 g of wheat flour and 50 mL of water. In total, 3 kg of flour were 
inoculated with each strain. The flasks were incubated at 25 ºC for 19 days in the case of F. 
graminearum and 8 days in the case of A. ochraceus, with periodic shaking. Then, each 
contaminated flour (3 kg) was properly homogenized and underwent either DON or OTA analysis. 
The content of DON and OTA was of 12,500±1,235 µg/kg and 75.5±15.2 µg/kg respectively (n=3), 
in each contaminated flour, while DON-3-glucoside level remained unchanged.  
Commercial wheat bran was used to obtain mycotoxin contaminated bran. The initial 
analysis of this bran showed that it was naturally contaminated (n=3) with DON (2,070 ±49 µg/kg). 
Analogously to the flour contamination procedure described above, a sublot of DON naturally 
contaminated bran was further contaminated with OTA by inoculation with A. ochraceus and 
subsequent incubation. Thus bran contaminated with both OTA and DON was obtained. The 
concentration of OTA (n=3) reached in such bran was 85.7±19.6 µg/kg. 
2.2. Dough preparation and baking 
Pieces of dough (260 g) were made with different contents of bran (0, 100, 200 and 300 
g/kg flour) and either with addition of sourdough or not. The desired DON and OTA concentration 
was achieved by adding either DON/OTA contaminated bran as well as DON/OTA contaminated 
flour and uninoculated flour.  
Different flour/bran mixes were prepared, depending on the bran content and toxin levels 
to be achieved: a) dough without bran, DON and OTA was added through contaminated flour, b) 
dough with 100 or 200 g bran/kg flour, which source of OTA was contaminated flour, while DON 
contamination came from both DON contaminated flour and commercial bran, c) dough with 200 
g bran/kg flour, which OTA contamination source was contaminated bran, while DON 
contamination came from both DON contaminated flour and commercial bran; d) dough with 300 
g bran/kg flour, where DON contamination source was commercial bran whereas OTA 
contamination came from flour. Table 1 summarizes all the initial mixtures prepared. In all cases, 
two levels of mycotoxin contamination were assayed: High mycotoxin contaminated (HMC) dough 
(n=30), with 1,197±319 µg/kg of DON, 20.6±14.8 µg/kg of DON-3-glucoside and 9.7±1.8 µg/kg of 
OTA, and low mycotoxin contaminated (LMC) dough (n=30), with 565±247 µg/kg of DON, 
23.9±16.9 µg/kg DON-3-glucoside and 0.9±0.2 µg/kg of OTA. These results come from the initial 
mixes prepared for the breadmaking processes of the assay.  
To each flour/bran mix (156 g), 2.3 g of salt, 4.7 g of sucrose, 4.7 g of lard, 6.2 g of 
commercial compressed yeast (Saccharomyces cerevisiae), and 3.1 g of flour improver 
(containing calcium carbonate, wheat flour, soya flour, lecithin, ascorbic acid and enzymes) were 
added. The dough was obtained by adding ca. 83 mL of water to the mixture. 
Level of DON and 
OTA concentration Source of DON Source of OTA 
g of bran/1000 g of 
flour Sourdough use 
H
ig
h 
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nc
en
tra
tio
n 
Flour Flour 0 
Yes 
No 
Flour and bran Flour 100 
Yes 
No 
Flour and bran Flour 200 
Yes 
No 
Flour and bran Bran 200 
Yes 
No 
Bran Flour 300 
Yes 
No 
Lo
w
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on
ce
nt
ra
tio
n 
Flour Flour 0 
Yes 
No 
Flour and bran Flour 100 
Yes 
No 
Flour and bran Flour 200 
Yes 
No 
Flour and bran Bran 200 
Yes 
No 
Bran Flour 300 Yes 
The sourdough was obtained from a bakery, and was refreshed every 8 days and stored 
at 4 ºC. For refreshment, one half of the sourdough was removed and the other half was mixed 
with water and wheat flour (50:50). Sourdough was added in 10% w/w total dough. Initial 
flour/bran mixtures were recalculated taking into account the amount of flour/water contained in 
the sourdough in order to make results as much comparable as possible. The addition of lactic 
acid bacteria (LAB) in the form of sourdough has been reported to have positive effects on wheat 
bread quality and shelf-life (Corsetti et al., 2000; Crowley et al., 2002). 
Table 1. Initial prepared flour/bran mixes to assay the factors: initial toxin concentration, 
bran concentrations, sourdough use and source of OTA, on DON and OTA fate during 
breadmaking.   
Dough was manually kneaded until held together with a non-sticky, smooth and satiny 
appearance and optimum handling properties. Rounded pieces weighing 260 g each were 
prepared. From this point, thermoprobes were always used in the dough to record fermentation 
and baking temperatures; in particular, probes were placed in the centre of the loaf and close to 
the surface. Doughs were covered with a damp cloth and fermentation was carried out at 30 ºC 
for 15 minutes. Then the pieces were placed in moulds, where the dough further fermented for 1 
hour at 30 ºC. After the fermentation a sample of 25 g was taken from every proofed dough and 
stored at -20 ºC until mycotoxin analysis (results for the finished bread were corrected 
accordingly). The proofed dough was then baked in an oven (Eurofred PE46SVR, Eurofred, 
Spain). Baking conditions were 180 ºC and 105 min. Such conditions were established on the 
basis of previous experiments to obtain suitable bread. After baking, a representative sample was 
taken and stored at -20 ºC until analysis.  
A full factorial design with mycotoxin level, bran content, and use of sourdough as 
assayed factors with three replicates was performed. 
 
2.3. Chemicals and reagents 
Mycotoxin standards were supplied by Sigma (Sigma-Aldrich, Alcobendas, Spain). 
Acetonitrile (purity 99.99%), methanol (purity 99.99%) and ethanol (purity 99.5%) were purchased 
from J.T. Baker (Deventer, The Netherlands). All solvents were LC grade. Filter paper (Whatman 
No. 1) was purchased from Whatman (Maidstone, UK). Immunoaffinity chromatography columns 
(IAC) for DON (DONPREP®) and OTA (OCHRAPREP®) extracts clean-up were purchased from 
R-Biopharm (Rhone LTD Glasgow, UK). Pure water was obtained from a milli-Q apparatus 
(Millipore, Billerica, MA, USA). Phosphate buffer saline (PBS) was prepared with potassium 
chloride (0.2 g) (Panreac, Castellar del Vallès, Spain), potassium dihydrogen phosphate (0.2 g) 
(purity 98-100%, Panreac, Castellar del Vallès, Spain), disodium phosphate anhydrous (1.16 g) 
(purity 99%, Panreac, Castellar del Vallès, Spain) and sodium chloride (8.0 g) (purity >99,5%, 
No 
Fisher Bioreagents, New Jersey, USA) in 1 L of pure water; the pH was brought to 7.4 with 
hydrochloric acid 1 M.  
 
2.4. Preparation of standard solutions 
 
OTA standard solution was dissolved in methanol at a concentration of 5.0 mg/mL and 
stored at 4 ºC in a sealed vial until use. The concentration in the stock solution was checked by 
UV spectroscopy according to AOAC Official methods of analysis (Horwitz and Latimer, 2006). 
Working standard solution (0.5, 0.01, 0.005, 0.001 and 0.0005 μg/mL) were prepared by 
appropriate dilution of known volumes of the stock solution with mobile phase and used to obtain 
calibration curves in the appropriated chromatographic system.  
DON standard solution was dissolved in ethanol at a concentration of 10.0 mg/mL and 
stored at 4 ºC. The concentration in the stock solution was checked by UV spectroscopy according 
to AOAC Official methods of analysis (Horwitz and Latimer, 2006). Working standards (50.0, 10.0, 
5.0, 1.0, 0.5, 0.1 and 0.05 μg/mL) were prepared as for OTA, as well as calibration curves.  
DON was dissolved in acetonitrile at a concentration of 10.0 mg/mL and stored at 4 ºC in 
a sealed vial until use. Working standards (1.0, 0.5, 0.1, 0.05 and 0.01 μg/mL) were prepared as 
for OTA, as well as calibration curves.  
2.5. Mycotoxins extraction, detection and quantification.  
Prior to extraction, all samples were dried at 40 ºC for 24 hours and weight loss recorded 
in order to present the results in an ‘as is’ basis (μg/kg) or in total content of toxin (μg or ng). 
Briefly, for OTA analysis, 5 g of ground sample (Ika, A11B) were extracted with 30 mL of 
extractant solution (60% acetonitrile, 40% water) by magnetically stirring for 10 min and filtered 
with filter Whatman number 1. 4 mL of filtered solution was diluted with 44 mL of PBS solution 
and loaded on the IAC column. After this, the column was washed with 20 mL of PBS and OTA 
was eluted by applying 1.5 mL of methanol grade HPLC (three times back flushing) and 1.5 mL 
of milli-Q water, consecutively. The purified extract was dried under nitrogen stream at 40 ºC. 
Each dried sample was resuspended with 0.5 mL of acetonitrile:water:acetic acid (57:41:2). OTA 
was determined by HPLC (Waters 2695®) coupled with a Multi λ Fluorescence Detector Waters 
2475®, an analytical column Waters Spherisorb® 5 μm ODS2, 4.6 x 250 mm. Excitation and 
emission wavelengths were set, respectively, at 330 and 463 nm. HPLC mobile phase consisted 
of acetonitrile, water and acetic acid (57:41:2). The mobile phase flow rate was 1 mL·min-1, the 
injection volume was 100 μL, and the retention time was 15 minutes. 
Regarding DON and DON-3-G, 5 g of ground sample (Ika, A11B) were extracted with 30 
mL of distilled water by magnetically stirring for 10 min. Then the sample was centrifuged for 8 
min at 1780 g. Supernatant was filtered through a glass microfiber filter. Five milliliters of filtered 
sample were loaded on the IAC column and the column washed with 10 mL of distilled water. 
DON and DON-3-glucoside were eluted by applying 1.5 mL of methanol grade HPLC (with three 
backflushing steps) and 1.5 mL of milli-Q water, consecutively. Zachariasova et al. (2012) 
confirmed the good cross-reactivity of DON-3-glucoside with the IAC DONPREP® columns. The 
purified extracts were dried under nitrogen stream at 40 ºC. Each dried sample was resuspended 
with 0.5 mL of the mobile phase solution (water:acetonitrile:methanol, 92:4:4). DON and DON-3-
glucoside were determined by HPLC (Waters 2695®) coupled with a UV/Visible dual λ absorbance 
Detector Waters 2487. Absorption wavelength was set at 220 nm. The HPLC mobile phase flow 
rate was 1.2 mL·min-1, the injection volume was 100 μL, and the retention time for DON and DON-
3-glucoside were 20 and 23 min, respectively. 
 
2.6. Methods performance  
The analytical methods used were assessed for linearity, precision and recovery. 
Standard curves were generated by linear regression of peak areas against concentrations (r2 
were 0.97, 0.96 and 0.99 for DON, DON-3-glucoside and OTA, respectively). Precision was 
established by determining OTA and DON levels in bread and DON and DON-3-glucoside in flour 
samples at least by triplicate, in those samples fortified in order to calculate the recovery rates. 
The limit of detection (LOD) was considered to be three fold the signal of blank noise, and the 
limit of quantification (LOQ) was calculated as 3 x LOD. Method performance characteristics for 
DON and OTA are summarized in Table 2.  
 
Table 2. Method performances for ochratoxin A (OTA). deoxynivalenol-3-glucoside (DON-
3-glucoside) and deoxynivalenol (DON) determination in some analyzed substrates.  
a LOD = Limit of detection. 
b LOQ = Limit of quantification. 
c Mean value ± standard deviation. 
d RSDr = relative standard deviation.  
 
Mycotoxin Product LODa  (μg/kg) LOQb (μg/kg) n Spiking level 
(μg/kg) 
Recovery (%)c RSDrd(%) 
OTA 
Bread 0.14 0.42 5 
5 
5 
0.5 
1.5 
3.0 
103.9±15.6 
110.1±13.0 
99.6±12.6 
4 
2 
1 
DON 
Bread 60 180 5 
5 
5 
100 
500 
1000 
100.0±16.3 
98.8±9.0 
102.3±5.3 
16 
9 
5 
Flour 60 180 3 300 123.3±30.3 41 
   3 500 87.4±8.6 7 
DON-3-G 
Flour 14 42 5 
5 
5 
50 
250 
500 
80.0±9.6 
79.7±4.8 
66.7±11.2 
12 
6 
18 
2.7. Statistics 
Multifactorial ANOVA was applied to assess the significance of sample traits in the 
observed mycotoxin concentration levels as well as in the calculated percentages of 
increase/reduction at a p<0.05. Moreover, HSD-Tukey tests were applied to establish significant 
differences among levels of factors (the significance level was set at 5%). The results obtained 
were processed in two different ways: a) DON, DON-3-glucoside or OTA content in each step (µg 
of DON and DON-3-glucoside or ng of OTA) and, b) concentration ‘as is’ (µg/kg of DON, DON-3-
glucoside and OTA in wet basis). In the first case it was possible to assess the real impact of the 
processing steps in the mycotoxins, while in the second one it is possible to draw conclusions on 
compliance of maximum permitted levels. For the ‘no kneaded mix’ results obtained for dry 
ingredients from the mycotoxin analysis were corrected for the amount of water to be added. 
3. Results and discussion 
3.1. Recorded temperatures  
The temperature probes placed in the inner part of the dough and near the surface 
recorded higher temperatures near the surface (Fig. 1). In the fermentation step, the temperature 
reached a maximum of 31 ºC and no differences existed between the internal and external part. 
During the baking process, the dough reached in the centre the maximum temperature (97 ºC) 
within the first 30 minutes of baking and slightly decreased afterwards; this decrease was probably 
due to the formation of the crust, which may hinder the penetration of heat. Near the surface the 
temperature kept on increasing and reached almost 120 ºC at the end of baking (far from the 180 
ºC oven baking temperature).  
 
 
Figure 1. Mean temperatures recorded during the bread making process in the center and 
near the crust. 
 
3.2. Effect of dough fermentation and baking on DON and DON-3-glucoside content 
Average DON content in the initial mixture and proofed dough was not significantly 
different (142.9 µg vs 122.7 µg for the overall mean, respectively) (p>0.05), although this 
difference depended on the other assayed factors. However, when percentages of reduction were 
calculated, and their variance analysed, the contribution of the sourdough and the initial 
concentration was significant (p<0.05), as well as their interactions. When sourdough was added, 
a mean increase of DON of 24% was observed, with lower values with increasing bran content 
and initial DON concentration. On the other hand, doughs prepared without sourdough suffered 
a mean reduction of DON of 7%, such reduction was higher with 300 g/kg bran and HMC (Fig. 
2a, 2b). Overall, doughs prepared with HMC suffered a mean 17% decrease in DON 
concentration, while those with LMC an increase of 33%.  
 
Figure 2. Percentage of increase in mean DON content (µg) ± SD due to dough kneading, 
fermentation and proofing as a function of bran level and presence of sourdough at the 
high (a) and low (b) initial DON concentration. 
A,B,C,D Different groups of letters next to the bars indicate significant differences among treatments, 
same groups of letters mean no significant difference (Tukey’s test p < 0.05). 
 
As the experiment was not designed for different levels of DON-3-glucoside in the initial 
flour mix, the natural levels detected in the mix of solid ingredients were not different in those 
treatments with high/low DON content, and the data were pooled, with a mean value before 
kneading of 3.5 μg, with most of the data under the limit of detection (the LOD value was used to 
calculate the mean). After fermentation, DON-3-glucoside was still undetectable in most of the 
treatments, thus although a mean 79% increase in DON-3-glucoside occurred, the significance 
of the different factors was not determined for this step.   
Published studies on the effect of fermentation on DON content generally showed an 
increase in DON content when fermented dough was compared to the kneaded dough and 
enzymes were used as flour improvers (Simsek et al., 2012; Suman et al., 2012; Vidal et al., 
2014). By contrast, when no improvers were used, no changes or reduction in DON concentration 
were observed (Konstelanska et al., 2011; Neira et al., 1997; Samar et al., 2001). In our case, 
although improvers were used and DON release was observed when sourdough was included in 
the recipe, reduction could be observed at HMC and high added bran. Some authors (Kostelanska 
et al., 2011; Zachariasova et al., 2012) concluded that the use of bakery improvers containing 
enzymes may lead to a higher relative increase in DON-3-glucoside (consistent with our results), 
than in DON. When proofed/fermented dough was compared to initial flour, no change or increase 
in DON was reported (Bergamini et al., 2010; Valle-Algarra et al., 2009), this fact may be 
explained by the results of Lancova et al. (2008) who suggested that a release of DON took place 
during kneading, it decreased during fermentation and further increased during proofing; in those 
studies in which proofed dough was compared directly to flour, these sub-steps were not 
considered and then the averaged results may be contradictory.  
In our assay an increase of DON content was observed in sourdough fermented samples 
(p<0.05). Bergamini et al. (2010) studied the fate of DON during the fermentation step using 
sourdough powder as well as bread making promoting agents. The authors reported a significant 
increase in DON level after fermentation (30-40 ºC for 45 to 85 minutes) and suggested that such 
increase could be due to the release of bound DON. Such release might be attributed to both 
enzymes contained in the improver and to the metabolism of sourdough bacteria which may be 
able to either transform DON precursors into DON or to release bound DON. In addition, Suman 
et al. (2012) prepared crackers with the sponge technique (fermentation for 2-4min at 20-30 ºC) 
and reported from 10% decrease to 14% increase in DON concentration compared to kneaded 
dough, depending on fermentation time and temperature and NaHCO3 concentration.  
Bran content did only affect the fermentation effect when added at 300 g·kg-1, leading to 
a more marked DON reduction; no studies exist in this point, only Scudamore et al. (2009) found 
similar global percentages of reduction for the whole breadmaking process from flour to bread of 
35% for white bread and of 39% for wholemeal bread. 
Average DON content in the fermented dough and bread was not significantly different 
(122.7 µg vs 126.2 µg, overall mean). Regarding the percentage of reduction/increase in DON 
content, it was independent of the factors assayed (DON concentration in flour, levels of bran and 
use of sourdough) and accounted for a mean value of 3% increase, although a trend existed for 
a certain release in sourdough containing samples and DON reduction without sourdough (Fig. 
3a, 3b). 
Figure 3. Percentage of increase in mean DON content (µg) ± SD due to baking as a 
function of bran level and presence of sourdough at the high (a) and low (b) initial DON 
concentration. 
A Same letter next to the bars indicate no significant differences among the treatments 
(Tukey’s 
test p < 0.05). 
 
 
As described before, DON-3-glucoside results for HMC and LMC samples were pooled, 
with most of the data under the limit of detection (the LOD value was used to calculate the mean) 
for kneaded+fermented dough. A significant increase of 229% (this value should be taken with 
care as only a few data for the fermented dough showed detectable values; and calculated values 
close the LOD may be inaccurate) was observed during baking (Fig. 4), which was independent 
of the assayed factors: bran concentration and sourdough addition. Similarly, Vidal et al. (2014) 
observed an increase of DON-3-glucoside after baking; however it could not be related to DON 
reduction. By contrast, previous studies reported DON-3-glucoside reduction during baking 
(Kostelanska et al., 2011; Simsek et al., 2012). The possible increase of DON-3-glucoside during 
baking is of concern; although little knowledge exists in the toxicological effects of DON-3-
glucoside, an important cleavage of DON-3-glucoside has been observed in the intestinal tract 
(Berthiller et al., 2011; Gratz et al., 2013). Thus DON-3-glucoside should be considered as an 
additional contributing factor of the total dietary exposure to DON (Codex, 2011; JEFCA, 2010). 
 
Figure 4. DON-3-glucoside content (μg) through the breadmaking process (Unkneaded 
mix, fermented dough and bread). 
A,B Different letters next to the bars indicate significant differences among the treatments, 
same letter no significant difference (Tukey’s test p < 0.05). 
 
Contradictory reports exist regarding the fate of DON during the baking step. Most studies 
reported DON reduction during baking (El-Banna et al., 1983; Scott et al., 1984; Valle-Algarra et 
al., 2009), while others (Bergamini et al., 2010; Simsek et al., 2012; Zachariasova et al., 2012) 
reported an increase in DON concentration after baking; two reasons could lead to such increase: 
i) shorter baking times together with lower temperatures and ii) bigger bread sizes, as in general 
those studies reporting reduction were usually at laboratory level with small size loaves (40-80 g). 
In our case, loaf size was bigger than in most published studies, and according to our temperature 
records the inner part of the dough did not reach more than 97 ºC. Probably, DON degradation 
took place exclusively in the crust but such degradation is not enough to detect a significant 
decrease in DON content in the whole sample. Finally, baking temperature in our study was lower 
than average studies and baking time longer, thus the absence of effect of baking does not 
contradict the general trend of the existing studies. 
 
3.3. Effect of dough fermentation and baking on OTA 
Due to the high OTA stability observed in preliminary studies, only those samples with 
200 g bran/kg flour were analysed. First of all, no significant differences were observed in the 
results when OTA was added either as contaminated flour or as contaminated bran. The total 
content of OTA (ng) did not significantly change during fermentation (p<0.05, mean of 1518 vs 
1581 ng at HMC, and mean of 143 vs 129 ng at LMC). No significant effect of sourdough addition 
was observed. 
The analysis of the sourdough used in this investigation resulted in a high concentration 
of lactic acid bacteria (1·107 CFU/g) which have been reported to be able to degrade OTA to 
ochratoxin α (OTα) (Varga et al., 2000). However, the time required to cause OTA degradation 
should be probably longer than that assayed herein.  
Although plant metabolism of OTA has been described in wheat, and OTα, (4R)- and 
(4S)-4-hydroxy-ochratoxin A and glucosides of both isomers have been found in large amounts, 
no studies exist either on their fate or their conversion from or to the parent molecule during 
processing of wheat derivatives.  
 
The total content of OTA (ng) tended to increase during baking although the trend was 
not significant (p=0.07, mean of 1581 vs 2291 ng at the HMC, and mean of 129 vs 245 ng at the 
LMC). Such increase (mean of 75%) did not depend on any of the assayed factors (initial OTA 
concentration in flour/bran and sourdough addition). 
The high OTA stability through baking observed in the present study is in accordance with 
Scudamore et al. (2003) and Vidal et al. (2014), under similar conditions. Some studies, however, 
reported OTA reduction during baking. Valle-Algarra et al. (2009) reached over 20% reduction in 
the baking bread process. Subirade (1996) also reported OTA reduction (66%) during baking 
process of wheat biscuits. However, due to the size and shape of such product the penetration of 
the heat may be higher. Moreover, studies on OTA stability in coffee showed very important 
reductions (over 90% in some assays) (Pérez de Obano et al., 2005; Van der Stegen et al., 2001), 
but the temperatures used are much higher than those used in cereal processing (approximately 
400 ºC). In summary, OTA in bread baking process seems to be stable and no reduction is 
observed.  
3.4. DON and DON-3-glucoside concentration in flour and bread ‘as is’ 
DON concentration in bread produced from a given flour batch will depend on the ‘dilution’ 
of the toxin with the addition of other ingredients, which depends on the recipe, to a minor extent 
on water, carbon dioxide and ethanol balance, and finally on the stability of the toxin through the 
process, which was explained in the previous sections.  
The results suggest that from flour with a contamination of 1197 µg/kg it is possible to 
produce bread with a significantly lower contamination (44-63%) depending on whether 
sourdough is used or not (Table 3), while the theoretical calculation taking into account the dilution 
effects of the process leads to a 40% reduction. On the other hand, from a lot of flour containing 
565 µg·kg-1, the final bread would contain DON levels 31% lower. This suggests that the diluting 
effect of the recipe may be either increased or limited, and even higher concentration of DON 
than expected thorough ingredients mixing can be encountered depending on initial DON 
concentration in the flour. This limited reduction is attributed to a certain increase in DON 
concentration during kneading and fermentation. Moreover, increase in DON concentration from 
proofed dough to bread was not significant, thus similar concentration can be observed in Table 
3.  
While DON-3-glucoside level in the fermented dough was not significantly different to that 
in the flour suggesting that the dilution effect was balanced by DON-3-glucoside increase during 
kneading and fermentation, a significant increase was observed from fermented dough to bread  
(Table 3). The resulting bread from flour containing 19.6 µg/kg might contain a concentration more 
than three times higher. Further studies are required to assess the significance of this fact, and 
the consequences it might have. 
Looking at DON results and literature, it seems that standard fermentation temperature, 
plus the widespread use of improvers might lead to a minimising of the ‘dilution’ effect due to 
recipe. According to Samar et al. (2001) higher fermentation temperatures, by contrast, may lead 
to DON degradation. The baking stage led to no significant reduction and, overall, a minimum 
17% reduction (mean 35%) can be expected for the breadmaking process from flour to bread (in 
a 260 g bread loaf, with improvers added), which is lower than the 33% assumed by Commission 
Regulation 1881/2006 setting a maximum level of 750 μg/kg for flour and 500 μg/kg for bread. In 
our case the only dilution effect would account for 40% reduction, but different recipes for bakery 
products could lead to much lower reduction, as suggested by Scudamore et al. (2003). On the 
other hand, DON-3-glucoside concentration greatly increased with baking; the increase could be 
the glycosidation of DON during the initial stages of baking, before enzyme inactivation (Vidal et 
al., 2014). This hypothesis is reinforced by the fact that DON-3-glucoside also increased during 
fermentation, and was previously suggested by Zachariasova et al. (2012). As a consequence, 
higher DON-3-glucoside concentration could be found in bread than in the initial flour (opposite 
of what reported by De Angelis et al., 2013). This point is of outmost importance as part of DON 
can be in vivo released from its conjugate (Berthiller et al., 2013) and should be further 
investigated. Moreover, a joint regulation of DON+DON-3-glucoside maximum levels might be 
proposed. 
Table 3. Evolution of mycotoxin concentration (μg/kg) in the different steps of 
breadmaking process (flour, fermented dough and bread). 
 
 Sourdough 
use 
Flour 
(μg/kg) 
Fermented 
dough ‘as is’ 
(μg/kg)* 
Bread ‘as 
is’ (μg/kg) 
% Reduction (kneading 
+fermentation+proofing)* 
30ºC 75 min 
% reduction 
baking 
D
O
N
 
Yes 1101 613 (661) 747 44 % (40%) -22 % 
563 389 (338) 469 31 % (40%) -21 % 
No 1293 474 (776) 588 63 % (40%) -24 % 
566 390 (340) 363 31 % (40%) 7% 
D
O
N
-3
-
gl
uc
os
id
e 
 19.6 20.8 (11.8) 73.8 -6 % (40%) -255 % 
O
TA
 
 
8.6 6.1 (5.2) 9.9 29 % (40%) -62 % 
0.8 0.5 (0.5) 1.1 38 % (40%) -54 % 
*values in parentheses are calculated taking into account only dilution by recipe 
 
3.5. OTA concentration in flour and bread ‘as is’ 
OTA concentration in bread produced from a given flour will depend only on the ‘dilution’ 
of the toxin with the addition of ingredients, and on a minor extent to water, carbon dioxide and 
ethanol balance due to OTA stability during the breadmaking process, as explained in the 
previous sections, although a trend to increase during baking was observed. Thus OTA 
concentration (wet basis) was reduced significantly by 29-38% from flour to fermented dough 
(theoretical decrease, assuming complete stability would be 40%). On the other hand, the 
average increase from fermented dough to bread was 58% (wet basis), although not significant 
(theoretical increase, assuming complete thermostability of OTA and 8% weight loss in the bread 
would be 9%). The whole breadmaking process could end in a concentration 1.4 times higher in 
bread than in the initial flour, which is in the line of an equal maximum level for both flour and 
bread (3 μg/kg), as set in the EC (2006). 
 
4. Conclusions 
As conclusion, OTA was confirmed to be quite stable during the breadmaking process. 
DON concentration was significantly affected by kneading+fermentation steps in different way 
depending on sourdough use and flour contamination level; while DON reduction by fermentation 
leads to a safer situation, the possible increase in DON should be considered with care, as it can 
compensate the expected dilution effect by recipe. Finally, the results on DON-3-G, although 
preliminary because a high percentage of samples were <LOD, suggest a marked release of this 
toxin during fermentation, but mainly during baking. This point, in particular, requires further 
investigation.  
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